[Diagnosis and treatment of bacterial infections of the lower respiratory tract. Comparative study: Tibirox versus erythromycin].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy*; D013411:Sulfadiazine / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013411:Sulfadiazine; D004917:Erythromycin; C026860:sulfadiazine, tetroxoprim drug combination
Diagnostic et traitement des infections bactériennes des voies respiratoires inférieures. Etude comparative: Tibirox versus erythromycine.